Two Sigma Advisers’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,100
| Closed | -$975K | – | 2427 |
|
|
2024
Q1 | $975K | Sell |
14,100
-2,900
| -17% | -$200K | ﹤0.01% | 1589 |
|
|
2023
Q4 | $937K | Buy |
17,000
+9,200
| +118% | +$507K | ﹤0.01% | 1672 |
|
|
2023
Q3 | $453K | Sell |
7,800
-600
| -7% | -$34.8K | ﹤0.01% | 1828 |
|
|
2023
Q2 | $452K | Buy |
8,400
+3,300
| +65% | +$178K | ﹤0.01% | 1844 |
|
|
2023
Q1 | $203K | Sell |
5,100
-1,600
| -24% | -$63.6K | ﹤0.01% | 2264 |
|
|
2022
Q4 | $270K | Sell |
6,700
-12,000
| -64% | -$483K | ﹤0.01% | 2101 |
|
|
2022
Q3 | $601K | Sell |
18,700
-34,500
| -65% | -$1.11M | ﹤0.01% | 1765 |
|
|
2022
Q2 | $1.58M | Sell |
53,200
-32,300
| -38% | -$958K | ﹤0.01% | 1334 |
|
|
2022
Q1 | $2.4M | Sell |
85,500
-1,300
| -1% | -$36.5K | 0.01% | 1154 |
|
|
2021
Q4 | $4M | Buy |
86,800
+48,800
| +128% | +$2.25M | 0.01% | 865 |
|
|
2021
Q3 | $1.25M | Sell |
38,000
-9,600
| -20% | -$315K | ﹤0.01% | 1513 |
|
|
2021
Q2 | $1.67M | Sell |
47,600
-7,800
| -14% | -$273K | ﹤0.01% | 1386 |
|
|
2021
Q1 | $2M | Sell |
55,400
-1,600
| -3% | -$57.8K | 0.01% | 1270 |
|
|
2020
Q4 | $1.66M | Buy |
57,000
+1,500
| +3% | +$43.6K | ﹤0.01% | 1351 |
|
|
2020
Q3 | $1.57M | Buy |
55,500
+14,400
| +35% | +$406K | ﹤0.01% | 1287 |
|
|
2020
Q2 | $1.33M | Buy |
+41,100
| New | +$1.33M | ﹤0.01% | 1435 |
|